KTELS Trademark
KTELS is a USPTO trademark filed by Nant Holdings IP, LLC. Status: Pending.
Prosecution Summary
Trademark Summary
The standard character mark KTELS covers cells and biological preparations for medical and clinical use, namely T cells activated by tumor-associated antigens or neoantigens, in International Class 005, along with goods and services in domestic classes 006, 018, 044, 046, 051, and 052. It is owned by Nant Holdings IP, LLC, a Delaware limited liability company based in Culver City, California. The application is under an intent-to-use basis and currently awaits a Statement of Use after a second extension of time was granted on October 2, 2025. No oppositions or legal proceedings are present.
Recent Activity
Filed on May 9, 2024, the application was approved for publication on June 28, 2024, published for opposition in the Official Gazette on August
Trademark Facts
| Mark | KTELS |
|---|---|
| Serial Number | 98542978 |
| Status | Pending |
| Filing Date | 2024-05-09 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Nant Holdings IP, LLC |
| Attorney of Record | Michael J. McCue |
| Prosecution Events | 20 |
| Latest Event | EXRA on 2026-03-25 |
Goods & Services
Cells and biological preparations intended for medical and clinical use, namely, T cells which have been activated by tumor-associated antigens or neoantigens expressed by a tumor